Two-fraction Ultrahypofractionated Radiotherapy with focal BOost for intermediate-risk, localized prostate cancer (TURBO): study protocol of a phase II, randomized controlled clinical trial

Abstract Background Hypofractionation in prostate cancer radiotherapy (RT) has drastically reduced fractionation schemes from 35 to 5 fractions for patients with intermediate-risk prostate cancer, providing good oncological outcomes and well-tolerated treatment toxicity. With an ageing population an...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	T. A. Lalmahomed, E. M. Monninkhof, M. J. van Rijssel, H. H. E. van Melick, H. M. Verkooijen, J. C. J. de Boer, J. R. N. van der Voort van Zyp
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2025-12-01
Seri Bilgileri:	Trials
Konular:	MR-guided adaptive radiotherapy Quality of life Patient-reported outcomes Prostate cancer Ultrahypofractionation
Online Erişim:	https://doi.org/10.1186/s13063-025-09297-5
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!